Chile researchers developed antibodies that neutralised the deadly Andes hantavirus in lab and animal tests, showing real promise against a rare virus that can spread between people. But the effort stalled before human trials, crushed by limited funding and the disruption of the Covid-19 pandemic.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
